Cargando…

Therapy Discontinuation after Myocardial Infarction

The discontinuation of recommended therapy after myocardial infarction predisposes patients to serious thrombotic complications. The aim of this study was a comprehensive analysis of permanent as well as short- and long-term discontinuation of pharmacotherapy, taking into consideration the basic gro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pietrzykowski, Łukasz, Kasprzak, Michał, Michalski, Piotr, Kosobucka, Agata, Fabiszak, Tomasz, Kubica, Aldona
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7766090/ https://www.ncbi.nlm.nih.gov/pubmed/33352811 http://dx.doi.org/10.3390/jcm9124109

Ejemplares similares

The impact of readiness to discharge from hospital on adherence to treatment in patients after myocardial infarction
por: Kosobucka, Agata, et al.
Publicado: (2022)

Adherence to treatment assessed with the Adherence in Chronic Diseases Scale in patients after myocardial infarction
por: Kosobucka, Agata, et al.
Publicado: (2018)

Medication adherence and its determinants in patients after myocardial infarction
por: Pietrzykowski, Łukasz, et al.
Publicado: (2020)

Effects of Multidisciplinary Rehabilitation Program in Patients with Long COVID-19: Post-COVID-19 Rehabilitation (PCR SIRIO 8) Study
por: Ostrowska, Małgorzata, et al.
Publicado: (2023)

Determinants of Lipid Parameters in Patients without Diagnosed Cardiovascular Disease—Results of the Polish Arm of the EUROASPIRE V Survey
por: Ratajczak, Jakub, et al.
Publicado: (2023)

Assessment of Selected Baseline and Post-PCI Electrocardiographic Parameters as Predictors of Left Ventricular Systolic Dysfunction after a First ST-Segment Elevation Myocardial Infarction
por: Fabiszak, Tomasz, et al.
Publicado: (2021)

Diagnostic Performance of Selected Baseline Electrocardiographic Parameters for Prediction of Left Ventricular Remodeling in Patients with ST-Segment Elevation Myocardial Infarction
por: Kasprzak, Michał, et al.
Publicado: (2021)

Determinants of the Level of Anti-SARS-CoV-2 IgG ANTibodiEs after Vaccination (DANTE-SIRIO 7) Study in a Large Cohort of Healthcare Workers
por: Krintus, Magdalena, et al.
Publicado: (2022)

Value of oral glucose tolerance test in the acute phase of myocardial infarction
por: Bronisz, Agata, et al.
Publicado: (2011)

ANalgesic Efficacy and safety of MOrphiNe versus methoxyflurane in patients with acute myocardial infarction: the rationale and design of the ANEMON-SIRIO 3 study: a multicentre, open-label, phase II, randomised clinical trial
por: Kubica, Aldona, et al.
Publicado: (2021)

Low dose of ROSuvastatin in combination with EZEtimibe effectively and permanently reduce low density lipoprotein cholesterol concentration independently of timing of administration (ROSEZE): A randomized, crossover study — preliminary results
por: Obońska, Karolina, et al.
Publicado: (2021)

Usefulness of C-reactive protein as a marker of early post-infarct left ventricular systolic dysfunction
por: Swiatkiewicz, Iwona, et al.
Publicado: (2012)

Diurnal Oscillations of Fibrinolytic Parameters in Patients with Acute Myocardial Infarction and Their Relation to Platelet Reactivity: Preliminary Insights
por: Boinska, Joanna, et al.
Publicado: (2022)

Genetic determinants of platelet response to clopidogrel
por: Kubica, Aldona, et al.
Publicado: (2011)

Value of C-Reactive Protein in Predicting Left Ventricular Remodelling in Patients with a First ST-Segment Elevation Myocardial Infarction
por: Swiatkiewicz, Iwona, et al.
Publicado: (2012)

Influence of METHoxyflurane on ANtiplatelet Effect of ticagrelor in patients with unstable angina pectoris: Rationale and a protocol of a randomized clinical METHANE-SIRIO 4 study
por: Niezgoda, Piotr, et al.
Publicado: (2022)

ACS network-based implementation of therapeutic hypothermia for the treatment of comatose out-of-hospital cardiac arrest survivors improves clinical outcomes: the first European experience
por: Kozinski, Marek, et al.
Publicado: (2013)

The role of selected adipokines and ghrelin in the prognosis after myocardial infarction in a 12-month follow-up in the presence of metabolic syndrome
por: Michalski, Błażej, et al.
Publicado: (2017)

Diurnal Variability of Platelet Aggregation in Patients with Myocardial Infarction Treated with Prasugrel and Ticagrelor
por: Adamski, Piotr, et al.
Publicado: (2022)

Comparison of bioavailability and antiplatelet action of ticagrelor in patients with ST-elevation myocardial infarction and non-ST-elevation myocardial infarction: A prospective, observational, single-centre study
por: Adamski, Piotr, et al.
Publicado: (2017)

Disease activity in axial spondyloarthritis after discontinuation of TNF inhibitors therapy
por: Sebastian, Agata, et al.
Publicado: (2017)

Long-term outcome of rotational atherectomy according to burr-to-artery ratio and changes in coronary artery blood flow: Observational analysis
por: Nowak, Aleksander, et al.
Publicado: (2022)

ST-segment elevation myocardial infarction after COVID-19 reinfection: The disseminated thrombotic process
por: Michalski, Tomasz A., et al.
Publicado: (2021)

High-risk percutaneous coronary intervention with Impella CP hemodynamic support. A case series and method presentation
por: Sukiennik, Adam, et al.
Publicado: (2017)

Effectiveness of Resistance Training with the Use of a Suspension System in Patients after Myocardial Infarction
por: Nowak, Agata, et al.
Publicado: (2020)

Partial posteromedial papillary muscle rupture as an early complication after acute inferior ST-elevation myocardial infarction treated with primary percutaneous intervention
por: Szymczyk, Ewa, et al.
Publicado: (2017)

The Use of Vibration Training in Men after Myocardial Infarction
por: Nowak-Lis, Agata, et al.
Publicado: (2022)

Ion channel inhibition with amiodarone or verapamil in symptomatic hospitalized nonintensive-care COVID-19 patients: The RECOVERY-SIRIO randomized trial
por: Navarese, Eliano P., et al.
Publicado: (2022)

Discontinuation of hormone replacement therapy after myocardial infarction and short term risk of adverse cardiovascular events: nationwide cohort study
por: Bretler, Ditte-Marie, et al.
Publicado: (2012)

Circulating biomarkers as predictors of left ventricular remodeling after myocardial infarction
por: Węgiel, Michał, et al.
Publicado: (2021)

Beta Blocker Use After Acute Myocardial Infarction in the Patient with Normal Systolic Function: When is it “Ok” to Discontinue?
por: Kezerashvili, Anna, et al.
Publicado: (2012)

Indoor cycling training in rehabilitation of patients after myocardial infarction
por: Gloc, Dagmara, et al.
Publicado: (2021)

Morphine delays and attenuates ticagrelor exposure and action in patients with myocardial infarction: the randomized, double-blind, placebo-controlled IMPRESSION trial
por: Kubica, Jacek, et al.
Publicado: (2016)

Frailty as a Predictor of In-Hospital Outcome in Patients with Myocardial Infarction
por: Węgiel, Michał, et al.
Publicado: (2022)

Sustained beneficial effect of β-blockers on clinical outcomes after discontinuation in patients with ST elevation myocardial infarction
por: Park, Jin-Sun, et al.
Publicado: (2023)

Giant coronary sinus secondary to partial anomalous pulmonary venous connection with combined mitral valve disease
por: Michalski, Błażej, et al.
Publicado: (2016)

Determinants of high platelet reactivity in patients with acute coronary syndromes treated with ticagrelor
por: Adamski, Piotr, et al.
Publicado: (2019)

Role of Endoglin (CD105) in the Progression of Hepatocellular Carcinoma and Anti-Angiogenic Therapy
por: Kasprzak, Aldona, et al.
Publicado: (2018)

The Use of Artificial Hypoxia in Endurance Training in Patients after Myocardial Infarction
por: Nowak-Lis, Agata, et al.
Publicado: (2021)

Symmetric Dimethylarginine is Altered in Patients After Myocardial Infarction and Predicts Adverse Outcomes
por: Gąsecka, Aleksandra, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_cauoi84big3f9567s6rtqavdal